Anti-Inflammatory Properties Of Cannabidiol, A Nonpsychotropic Cannabinoid, In Experimental Allergic Contact Dermatitis
Phyocannabinoids modulate inflammatory responses by regulating the production of cytokines in several experimental models of inflammation. Cannabinoid type-2 (CB2) receptor activation was shown to reduce the production of the monocyte chemotactic protein-2 (MCP-2) chemokine in polyinosinic-polyctidylic acid-stimulated human keratinocyte cells, an in vitro model of allergic contact dermatitis.
Cannabidiol Effects On Phospholipid Metabolism In Keratinocytes From Patients With Psoriasis Vulgaris
Psoriasis is a chronic inflammatory skin disease characterized by dysregulated keratinocyte differentiation, but oxidative stress also plays an important role in the pathogenesis of this disease. Here, we examined the effect of cannabidiol (CBD), a phytocannabinoid with antioxidant and anti-inflammatory properties, on the redox balance and phospholipid metabolism in UVA/UVB-irradiated keratinocytes isolated from the skin of psoriatic patients or healthy volunteers.
Cannabidiol Exerts Sebostatic And Anti-inflammatory Effects On Human Sebocytes
The endocannabinoid system (ECS) regulates physiological processes, including cutaneous cell growth and differentiation. Here, we explored the effects of the major nonpsychotropic phytocannabinoid of Cannabis Sativa, on human sebaceous gland function and determined that CBD behaves as a highly effective sebostatic agent.
Cannabidiol Induces Antioxidant Pathways In Keratinocytes By Targeting BACH1
Cannabidiol (CBD) is a major non-psychotropic phytocannabinoid that attracted a great attention for its therapeutic potential against different pathologies including skin diseases. However, although the efficacy in preclinical models and the clinical benefits of CBD in humans have been extensively demonstrated, the molecular mechanism(s) and targets responsible for these effects are as yet unknown.
Cannabis Sativa And Skin Health: Dissecting The Role Of Phytocannabinoids
The use of Cannabis sativa is currently recognized to ease certain types of chronic pain, reduce chemotherapy-induced nausea, and improve anxiety. Nevertheless, few studies highlighted the therapeutic potential of C. sativa extracts and related phytocannabinoids for a variety of widespread skin disorders including acne, atopic dermatitis. psoriasis, pruritus, and pain.
The Differential Effect Of Cannabidiol On The Composition And Physicochemical Properties Of Keratinocyte And Fibroblast Membranes From Psoriatic Patients And Healthy People
The development of psoriasis is accompanied by oxidative stress, which can modify the components of skin cells. Therefore, the aim of this study was to evaluate the effect of cannabidiol (CBD), an antioxidant and anti-inflammatory phytocannabinoid, on the composition and physicochemical properties of the membranes of healthy and psoriatic keratinocytes and fibroblasts exposed to ultraviolet A (UVA) and ultraviolet B (UVB) radiation.
Therapeutic Application Of Cannabidiol On UVA And UVB Irradiated Rat Skin. A Proteomic Study
UV phototherapy used in chronic skin diseases causes redox imbalance and pro-inflammatory reac-tions, especially in the case of unchanged skin cells. To prevent the harmful effects of UV radiation, cannabidiol (CBD) has been used, which has antioxidant and anti-inflammatory properties. Therefore, the aim of this study was to evaluate the effect of CBD on the metabolism of skin keratinocytes in nude rats exposed to UVA/UVB radiation using a proteomic approach.